These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 31137948

  • 21. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease.
    Furman K, Gut P, Sowińska A, Ruchała M, Fichna M.
    Endocrine; 2024 May; 84(2):711-719. PubMed ID: 38334892
    [Abstract] [Full Text] [Related]

  • 22. Bone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study.
    Zhang L, Su Y, Hsieh E, Xia W, Xie J, Han Y, Cao Y, Li Y, Song X, Zhu T, Li T, Yu W.
    BMC Musculoskelet Disord; 2013 Jul 30; 14():224. PubMed ID: 23899016
    [Abstract] [Full Text] [Related]

  • 23. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy.
    Hoy J, Grund B, Roediger M, Ensrud KE, Brar I, Colebunders R, Castro ND, Johnson M, Sharma A, Carr A, INSIGHT SMART Body Composition Substudy Group.
    J Bone Miner Res; 2013 Jun 30; 28(6):1264-74. PubMed ID: 23299909
    [Abstract] [Full Text] [Related]

  • 24. The relationship between the metabolic syndrome and its components and bone status in postmenopausal women.
    Fodor D, Vesa S, Albu A, Simon S, Craciun A, Muntean L.
    Acta Physiol Hung; 2014 Jun 30; 101(2):216-27. PubMed ID: 24901081
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women.
    Adami S, Zivelonghi A, Braga V, Fracassi E, Gatti D, Rossini M, Ulivieri FM, Viapiana O.
    Bone; 2010 Jan 30; 46(1):244-7. PubMed ID: 19853071
    [Abstract] [Full Text] [Related]

  • 27. Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
    Klassen KM, Kimlin MG, Fairley CK, Emery S, Anderson PH, Ebeling PR, STEAL Study Group.
    Osteoporos Int; 2016 May 30; 27(5):1737-45. PubMed ID: 26659069
    [Abstract] [Full Text] [Related]

  • 28. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
    Kharroubi A, Saba E, Smoom R, Bader K, Darwish H.
    Arch Osteoporos; 2017 Dec 30; 12(1):13. PubMed ID: 28124221
    [Abstract] [Full Text] [Related]

  • 29. Associations of Bone Mineral Density and Bone Metabolism Indices with Urine Albumin to Creatinine Ratio in Chinese Patients with Type 2 Diabetes.
    Zhao X, Zhang XM, Yuan N, Yu XF, Ji LN.
    Exp Clin Endocrinol Diabetes; 2019 Jan 30; 127(1):50-55. PubMed ID: 30396213
    [Abstract] [Full Text] [Related]

  • 30. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z, Jin X, Bian P, Li X, Chen J.
    Geriatr Gerontol Int; 2017 May 30; 17(5):773-778. PubMed ID: 27137883
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Early changes in bone turnover and inflammatory biomarkers and clinically significant bone mineral density loss over 48 weeks among HIV-infected patients with virological failure of a standard first-line antiretroviral therapy regimen in the SECOND-LINE study.
    Mwasakifwa GE, Amin J, White CP, Center JR, Kelleher A, Boyd MA.
    HIV Med; 2020 Sep 30; 21(8):492-504. PubMed ID: 32573910
    [Abstract] [Full Text] [Related]

  • 33. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients.
    Jeong JU, Lee HK, Kim YJ, Kim JS, Kang SS, Kim SB.
    Clin Nephrol; 2010 Nov 30; 74(5):336-42. PubMed ID: 20979940
    [Abstract] [Full Text] [Related]

  • 34. Observational Study to Evaluate the Effect of Epidural Steroid Injection on Bone Mineral Density and Bone Turnover Markers.
    Jain A, Gupta P, Chaurasia R, Singh M, Pandey S.
    Pain Physician; 2020 Sep 30; 23(5):E517-E524. PubMed ID: 32967402
    [Abstract] [Full Text] [Related]

  • 35. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M, Fukunaga M, Ohtawa T, Harada T.
    World J Surg; 1996 Sep 30; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [Abstract] [Full Text] [Related]

  • 36. 25-Hydroxyvitamin-D and Bone Turnover Marker Levels in Patients with Distal Radial Fracture.
    Rozental TD, Herder LM, Walley KC, Zurakowski D, Coyle K, Bouxsein ML, Wolf JM.
    J Bone Joint Surg Am; 2015 Oct 21; 97(20):1685-93. PubMed ID: 26491133
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy.
    Alonso S, Ferrero E, Donat M, Martínez G, Vargas C, Hidalgo M, Moreno E.
    J Endocrinol Invest; 2012 Jul 21; 35(7):640-4. PubMed ID: 21946027
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.